Back
The Cigna Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
68
CI
The Cigna Group
Last Price:
$330.17
Seasonality Move:
3.24%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
$51.00
Seasonality Move:
12.51%
Buy
68
The Cigna Group (CI)
is a Buy
Is The Cigna Group a Buy, Sell or Hold?
-
The current The Cigna Group [CI] share price is $330.19. The Score for CI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
CI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $51.03. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CI Stock Price Chart
What is The Cigna Group's stock price today?
-
The The Cigna Group share price today is $330.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CI is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $51.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
CI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.97 | Buy |
Relative Strength Index (14 RSI): | 58.41 | Buy |
Chaikin Money Flow: | 794931 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (314.91 - 328.35) | Buy |
Bollinger Bands (100): | (285.37 - 324.69) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.25 | Sell |
Relative Strength Index (14 RSI): | 26.54 | Sell |
Chaikin Money Flow: | 1747021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.57 - 90.55) | Sell |
Bollinger Bands (100): | (83.88 - 128.16) | Sell |
CI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 324.93 | Buy |
20-day SMA: | 323.29 | Buy |
50-day SMA: | 310.27 | Buy |
200-day SMA: | 322.41 | Buy |
8-day EMA: | 324.64 | Buy |
20-day EMA: | 321.91 | Buy |
50-day EMA: | 314.23 | Buy |
200-day EMA: | 316.36 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.28 | Sell |
20-day SMA: | 66.37 | Sell |
50-day SMA: | 91.18 | Sell |
200-day SMA: | 120.65 | Sell |
8-day EMA: | 55.11 | Sell |
20-day EMA: | 66.27 | Sell |
50-day EMA: | 84.86 | Sell |
200-day EMA: | 110.43 | Sell |
The Cigna Group Earnings Growth & CI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.62 per share, an increase this year of $1.22 per share, and an increase next year of $3.24 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $4.38 per share, and an increase next year of $5.87 per share.
The Cigna Group Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |